Jacquelyn Bainbridge

University of Colorado Anschutz Medical Campus — United States

Medicine · Health Sciences

25h-index3.1kcitations74works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epilepsy research and treatment(24), Pharmacological Effects and Toxicity Studies(21), Parkinson's Disease Mechanisms and Treatments(16), Cannabis and Cannabinoid Research(10), Pharmaceutical Practices and Patient Outcomes(8)

Publications74 total

Cannabis, Pain, and Complications: A Prospective Analysis of Cannabis Use, Opiate Consumption, and Postoperative Outcomes following Cancer-Related Abdominal Surgery
Annals of Surgical Oncology·2025
Cannabidiol for treatment of irritability and aggressive behavior in children and adolescents with autism spectrum disorder: background and methods of the cannabidiol study in children with autism spectrum disorder study
International Journal of Clinical Trials·2025Open Access
EPH219 Desk-Sharing in Workplaces: Economic Analysis of Targeted Hygiene Intervention (THI) in Reducing Risk of Common Infections
Value in Health·2024Open Access
The Fundamentals of Antiseizure Medications: A Through Z
Epiliepsy currents/Epilepsy currents·2024Open Access
Cannabidiol for treatment of Irritability and Aggressive Behavior in Children and Adolescents with ASD: Background and Methods of the CAnnabidiol Study in Children with Autism Spectrum DisordEr (CASCADE) Study
2024· 1 citedOpen Access
Short‐Term Cannabidiol with Δ‐9‐Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial
Movement Disorders·2024· 15 citedOpen Access
Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial
JMIR Dermatology·2024· 5 citedOpen Access
EVALUATING THE COST-EFFECTIVENESS OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A CANADIAN HEALTHCARE PAYER PERSPECTIVE
Canadian Journal of Diabetes·2023
EVALUATING THE COST-EFFECTIVENESS OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A CANADIAN HEALTHCARE PAYER PERSPECTIVE
Canadian Journal of Cardiology·2023
Highlights From the Annual Meeting of the American Epilepsy Society 2022
Epiliepsy currents/Epilepsy currents·2023· 2 citedOpen Access
The Role of Clinical Pharmacists in Patient-Centric Comprehensive Multiple Sclerosis Care
International Journal of MS Care·2023· 6 citedOpen Access
Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial (Preprint)
2023Open Access
Cognitive Safety Data from a Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase <scp>IIb</scp> Study of the Effects of a Cannabidiol and <scp>Δ9</scp>‐Tetrahydrocannabinol Drug on Parkinson's Disease‐Related Motor Symptoms
Movement Disorders·2023· 30 citedOpen Access
ETHOSUXIMIDE
Clinical Pharmacokinetics·2022
CARBAMAZEPINE
Clinical Pharmacokinetics·2022
ANTIEPILEPTICS
Clinical Pharmacokinetics·2022
Acute akathisia following initiation of opicapone: A case report
Clinical Parkinsonism & Related Disorders·2022· 1 citedOpen Access
Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson Disease: Interim Report on Tolerability (1592)
Neurology·2021· 1 cited
Saroglitazar magnesium improves lipid parameters in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis
Atherosclerosis·2020
Would people living with epilepsy benefit from palliative care?
Epilepsy & Behavior·2020· 12 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Robert L. Page(6), Maureen A. Leehey(5), Jost Klawitter(5), Cristina Sempio(5), Pei Shieen Wong(5), Ying Liu(4), Felecia Hart(4), Stefan Sillau(4), Michael J. Aminoff(4), David K. Simon(4), Carlos Singer(4), Sarah Fischer(3), Anne‐Marie Wills(3), J. Mark Ruscin(3), Mark C. Spitz(3), Barbara C. Tilley(3), Jay S. Schneider(3), Saloni Sharma(3), Jolene R. Bostwick(3), David Gloss(2)